# A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

> **NCT07201584** · PHASE1 · RECRUITING · sponsor: **Berlin-Chemie AG Menarini Group** · enrollment: 26 (estimated)

## Conditions studied

- Healthy Adult Male and Female Volunteers

## Interventions

- **DRUG:** Torasemide tablet 10 mg
- **DRUG:** Unat® 10 tablets (Torasemide 10 mg)

## Key facts

- **NCT ID:** NCT07201584
- **Lead sponsor:** Berlin-Chemie AG Menarini Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-04-01
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201584, "A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07201584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*